If you live in Canada, Australia, India or Japan and you're buying an Apple Watch Series 12 or Ultra 4 for its hypertension alerts, check first. The feature may not work there yet.
The Mac Observer found a footnote on Apple's watchOS feature availability page. It sits next to 33 countries and regions and says "additional regulatory clearances for these devices are in process." Apple gives no date for when those clearances will finish. Apple's support document for the feature, published September 14, carries the same caveat.
The footnote names only the two new watches. That's the odd part. Hypertension notifications already run on older models in many of these places. The feature itself isn't new there. The new hardware is what hasn't been cleared.
It covers Australia, Brazil, Canada, Colombia, India, Indonesia, Israel, Japan, Malaysia, Saudi Arabia, Singapore, South Africa, South Korea, Taiwan, Thailand, Türkiye, Ukraine, the United Arab Emirates and Vietnam, among others. The United States, the United Kingdom, Hong Kong, New Zealand, Chile and EU countries such as France, Germany, Italy and Spain carry no footnote. Mexico and China aren't on Apple's hypertension list at all.
When The Mac Observer checked on September 15, the US and UK Series 12 pages described hypertension notifications. The Canadian, Indian, Australian and Japanese pages didn't mention the feature.
It helps to be clear about what the feature does. The watch does not take your blood pressure. Apple says the optical heart sensor feeds an algorithm that studies how your blood vessels respond to each heartbeat over 30-day periods. If it sees a pattern that points to long-term high blood pressure, it tells you, and prompts you to log readings from a regular cuff for a week. Apple says it is not a diagnosis, and that not everyone with hypertension will get an alert. A quiet watch doesn't mean your blood pressure is fine.
So who should care? Two groups.
If you're upgrading in one of the 33 regions and this feature is the reason, wait until Apple's availability page drops the footnote for your country. A regulatory clearance can take weeks or months, and Apple hasn't said which.
If you already use hypertension alerts on a Series 9 or later, or an Ultra 2 or later, nothing changes for you. The footnote is about the new watches only. Upgrading could mean trading a feature that works today for one that's waiting on a regulator.
This is the part of health wearables that rarely makes the keynote. A sensor can ship worldwide on the same day. Permission to tell you what it found does not.